|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 900 7th Street, NW |
Address2 | Suite 750 |
City | Washington |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 72111-12
|
||||||||
|
6. House ID# 359400000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Tracy Spicer, Principal |
Date | 04/19/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 3200, America's Affordable Health Choices Act - coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse;
HR 3590, Patient Protection and Affordable Care Act - coverage expansions, quality improvements, delivery system reforms, cost containment, health information technology, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse;
HR 3962, Affordable Health Care for America Act - coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse;
HR 4213, Tax Extenders Act - COBRA assistance;
HR 4691, Temporary Extension Act - COBRA assistance;
HR 4851, Continuing Extension Act - COBRA assistance, electronic health records;
S 139, Data Breach Notification Act - data security;
S 1213, Patient-Centered Outcomes Research Act - comparative effectiveness research;
S. 1490, Personal Data Privacy and Security Act - privacy, identity theft;
S 1679, Affordable Health Choices Act - coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse;
S. 1796, American's Healthy Future Act - coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Barnett |
|
|
|
Tracy |
Spicer |
|
|
|
Amy |
Tejral |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 1721, CLASS Act - national LTC program;
HR 2360, SHOP Act - small employer health options;
HR 3200, America's Affordable Health Choices Act - government run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance;
HR 3590, Patient Protection and Affordable Care Act - government run health plan, health insurance cooperatives, multi-state plans, insurance market reforms, health insurance exchanges, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance, federal rate review process, health care choice compacts, appeals procedures, disclosure requirements, high risk pool program, McCarran-Ferguson Act;
HR 3962, Affordable Health Care for America Act - government run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance, federal rate review process, health care choice compacts, high risk pool program, McCarran Ferguson Act;
HR 4757, Health Insurance Rate Authority Act - federal rate review process;
HR 4872, Health Care and Education Reconciliation Act - changes to individual coverage requirement, grandfathered plans, immediate insurance reforms, premium assistance, CLASS Act, coverage issues, quality improvements, delivery system reforms;
S 391, Healthy Americans Act - comprehensive health reform;
S 697, CLASS Act - national LTC program;
S 979, SHOP Act - small employer health options;
S 1177, Confidence in Long-Term Care Insurance Act - LTC consumer protections;
S 1679, Affordable Health Choices Act - government run health plan, insurance market reforms, health benefit gateways, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance;
S 1681, Health Insurance Industry Antitrust Enforcement Act - changes to McCarran Ferguson Act;
S 1796, America's Health Future Act - government run health plan, health insurance cooperatives, health insurance exchange, insurance market reforms, individual coverage requirement, benefit packages, premium assistance, medical loss ratios, regulatory reform;
S 3078, Health Insurance Rate Authority Act - federal rate review process
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Barnett |
|
|
|
Tracy |
Spicer |
|
|
|
Amy |
Tejral |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 3200, America's Affordable Health Choices Act - Medicare Advantage, Part D, special needs plans, Medicare cost plans, Medicaid issues including MCO provider taxes and eligibility expansion, Medigap open enrollment, Medicare FFS payment reform;
HR 3590, Patient Protection and Affordable Care Act - Medicare Advantage, Part D, special needs plans, Medicare cost plans, Medicaid issues including eligibility expansion and prescription drug pricing, Medigap changes, Medicare FFS payment reform;
HR 3961, Medicare Physician Payment Reform Act - Medicare physician payment;
HR 3962, Affordable Health Care for America Act - Medicare Advantage, Part D, speical needs plans , Medicare cost plans, Medicaid issues including MCO provider taxes, eligibility expansion and prescription drug pricing, Medigap changes, Medicare FFS payment reform;
HR 4213, Tax Extenders Act - Medicare Advantage, special needs plans, cost plans, Medicare physician payment, Medicaid FMAP;
HR 4691, Temporary Extension Act - Medicare physician payment;
HR 4851, Continuing Extension Act - Medicare physician payment;
HR 4872, Health Care and Education Reconciliation Act - changes to Medicare Advantage funding, Medicare Part D coverage gap, Medicaid funding;
HR Res 45 - Medicare physician payment, pay-as-you-go rules;
S 960, Medicare Early Access Act - Medicare buy-in option;
S 1307, Medicare Specialty Care Improvement and Protection Act - Medicare Advantage special needs plans;
S 1380, MedPAC Reform Act - implementation of Medicare payment policies;
S 1796, America's Healthy Future Act - Medicare Advantage, Part D, special needs plans, Medicaid issues including eligibility expansion and prescription drug rebates, Medigap restrictions, Medicare FFS payment reform;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Barnett |
|
|
|
Tracy |
Spicer |
|
|
|
Amy |
Tejral |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies;
HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics;
HR 1548, Pathway for Biosimilars Act - generic biologics;
HR 3200, America's Affordable Health Choices Act - generic biologics;
HR 3590, Patient Protection and Affordable Care Act - generic biologics;
HR 3962, Affordable Health Care for America Act - generic biologics;
S 369, Preserve Access to Affordable Generics Act - generic drugs;
S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics;
S 1679, Affordable Health Choices Act - generic biologics
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Barnett |
|
|
|
Tracy |
Spicer |
|
|
|
Amy |
Tejral |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 3590, Patient Protection and Affordable Care Act - premium tax, high-value health plan tax, LTC insurance in cafeteria plans, FSA limits, tax exclusion for FSAs and HRAs, health savings accounts, tax deduction for itemized medical expenses;
HR 3962, Affordable Health Care for America Act - FSA limits, health savings accounts, eligibility of OTC drugs as tax-free expense;
HR 4872, Health Care and Education Reconciliation Act - changes to premium tax, high-value health plan tax;
S 1679, Affordable Health Choices Act - LTC insurance in cafeteria plans;
S 1796, America's Healthy Future Act - high cost health plan tax, industry tax, LTC insurance in cafeteria plans, FSA limits, employer tax exclusion, tax exclusion for FSAs and HRAs, health savings accounts, tax deduction for itemized medical expenses
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Barnett |
|
|
|
Tracy |
Spicer |
|
|
|
Amy |
Tejral |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |